Stay updated on CR845 for Atopic Dermatitis Pruritus: Clinical Trial
Sign up to get notified when there's something new on the CR845 for Atopic Dermatitis Pruritus: Clinical Trial page.

Latest updates to the CR845 for Atopic Dermatitis Pruritus: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check21 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of difelikefalin (CR845) for treating moderate to severe pruritus in adults with atopic dermatitis, and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference16%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check78 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check86 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
Stay in the know with updates to CR845 for Atopic Dermatitis Pruritus: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CR845 for Atopic Dermatitis Pruritus: Clinical Trial page.